Ryan Kelly

Hematology Account Specialist

Ryan.Kelly@pfizer.com

724-355-2404

 

 

 

 

 

 

 

 

 

 

 

                         

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 23 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma.

Click here to visit the Pfizer Virtual Booth

 

                             

                           

                            

 

 

Back to Virtual Hall